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RESEARCH ARTICLE
Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia
satureiifolia var. satureiifolia
Marı́a Florencia Beera,b, Fernanda Maria Frankc,d, Orlando Germán Elsoa,c, Augusto Ernesto Bivonac,d,
Natacha Cernyc,d, Gustavo Gibertia, Emilio Luis Malchiodic,d, Virginia Susana Martinoa,e, Marı́a Rosario Alonsoa,
Valeria Patricia Sülsena,e*, and Silvia Ines Cazorlac,d*
aInstituto de Quı́mica y Metabolismo del Fármaco (IQUIMEFA) (UBA-CONICET), Facultad de Farmacia y Bioquı́mica, Universidad de Buenos
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Buenos Aires, Argentina; dInstituto de Microbiologı́a y Parasitologı́a Médica (IMPaM) (UBA-CONICET), Facultad de Medicina, Buenos Aires,
Argentina; eCátedra de Farmacognosia, Facultad de Farmacia y Bioquı́mica, Universidad de Buenos Aires, Buenos Aires, Argentina
ABSTRACT
Context Chagas’ disease and leishmaniasis produce significant disability and mortality with great
social and economic impact. The genus Stevia (Asteraceae) is a potential source of antiprotozoal
compounds.
Objective Aerial parts of four Stevia species were screened on Trypanosoma cruzi. Stevia
satureiifolia (Lam.) Sch. Bip. var. satureiifolia (Asteraceae) dichloromethane extract was selected for a
bioassay-guided fractionation in order to isolate its active compounds. Additionally, the
antileishmanial activity and the cytotoxicity of these compounds on mammalian cells were
assessed.
Materials and methods The dichloromethane extract was fractionated by column chromatog-
raphy. The isolated compounds were evaluated using concentrations of 0–100 mg/mL on T. cruzi
epimastigotes and on Leishmania braziliensis promastigotes for 72 h, on trypomastigotes and
amastigotes of T. cruzi for 24 h and 120 h, respectively. The compounds’ cytotoxicity (12.5–
500mg/mL) was assessed on Vero cells by the MTT assay. The structure elucidation of each
compound was performed by spectroscopic methods and HPLC analysis.
Results The dichloromethane extracts of Stevia species showed significant activity on T. cruzi
epimastigotes. The flavonoids eupatorin (1.3%), cirsimaritin (1.9%) and 5-desmethylsinensetin
(1.5%) were isolated from S. satureiifolia var. satureiifolia extract. Eupatorin and 5-desmethylsi-
nensetin showed IC50 values of 0.2 and 0.4 mg/mL on T. cruzi epimastigotes and 61.8 and
75.1mg/mL on trypomastigotes, respectively. The flavonoid 5-desmethylsinensetin showed
moderate activity against T. cruzi amastigotes (IC50 value¼78.7 mg/mL) and was the most active
compound on L. braziliensis promastigotes (IC50 value¼37.0mg/mL). Neither of the flavonoids
showed cytotoxicity on Vero cells, up to a concentration of 500mg/mL.
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Introduction
Chagas’ disease results in significant disability with great
social and economic impact, including under- and
unemployment. About 6–7 million people are estimated
to be infected worldwide, mostly in Latin America with
almost 12 000 deaths annually (DNDi 2015a; WHO
2015). Although endemic in 21 countries across Latin
America, the number of affected people is growing in
non-endemic, developed countries due to increased
migration of Latin American people unknowingly
carrying the parasite (Rodriguez Coura & Albajar
Viñas 2010). Chagas’ disease is the most important
endemic disease in Argentina with 1.6–2 million people
being infected. This parasite disease affects mainly
people living in rural areas, where the vector lives, and
people from urban centres due to migration phenomena
(Franco-Paredes et al. 2009, Rassi et al. 2010).
Leishmaniasis is another poverty-associated disease
responsible for different clinical forms, the most
common being visceral leishmaniasis (VL) and cutane-
ous leishmaniasis (CL). The most common form in our
country is the CL caused mainly by L. braziliensis, but
since 2006, human and canine VL cases have been
reported (Gould et al. 2013). Mixed infections caused by
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Leishmania spp. and T. cruzi have been reported
in Argentina and Brazil (Chiaramonte et al. 1999;
Frank et al. 2003).
Current treatment for Chagas’ disease is limited to two
drugs, benznidazol and nifurtimox, which were devel-
oped around 30 years ago. These two drugs are effective
in the acute phase of infection and present drawbacks
associated to side effects, lack of effectiveness and long
treatment periods (DNDi 2015b). Leishmaniasis treat-
ment includes pentavalent antimonials (sodium stibo-
gluconate and meglumine antimoniate), amphotericin B,
miltefosine and paromomycin. These drugs have limita-
tions due to serious side effects, resistance, long duration
of treatment, low tolerability, difficult administration
and high cost (DNDi 2015b).
In recent years, considerable attention has been given
to secondary metabolites from plants in the search for
new trypanocidal and leishmanicidal compounds. Among
these metabolites, terpenes and flavonoids have been
pointed out as promising molecules (Schmidt et al. 2012).
The genus Stevia (Asteraceae) is a New World genus,
distribution ranging from the Southern United States to
Northeastern Paraguay, Southeastern Brazil and the South
American Andean region (Kinghorn 2002). One member
of this family, Stevia rebaudiana (Bertoni) Bertoni
(Asteraceae) is of worldwide economic importance
today since its ent-kaurene diterpene glycosides are used
as non-nutritive natural sweeteners, mainly in Japan. This
genus is rich in sesquiterpene lactones and flavonoids
among which, methoxylated aglycones at the C-6 position
have been reported (Cerda-Garcı́a Rojas & Pereda-
Miranda 2002). Flavonoids of this type, such as hispidulin
and santin, have been reported to have trypanocidal and
leishmanicidal activities (Sülsen et al. 2007).
In Argentina, the genus Stevia is represented by more
than 30 species and several varieties growing in the
Northern and Central areas of the country (Zuloaga et al.
2008). Among the native species, the chemical compos-
ition and bioactivity of Stevia aristata D. Don ex Hook.
&Arn., S. multiaristata Spreng., S. entreriensis Hieron.
and S. satureiifolia (Lam.) Sch. Bip. var. satureiifolia have
not been investigated so far. The only literature data
available on the chemical composition of S. aristata were
published by Zdero et al. (1987) in which beyerene
derivatives and other terpenoids were reported. Thus, the
potential of these species is still unexplored.
In this work, four native Stevia species were screened
for their antiprotozoal activity on Trypanosoma cruzi.
One of the most active species was selected for a
bioassay-guided fractionation in order to isolate its active
compounds. Additionally, the antileishmanial activity
and the cytotoxicity of these compounds on mammalian
cells were assessed.
Materials and methods
General experimental procedures
UV spectra were recorded on a Jasco-630 spectropho-
tometer (Jasco Tools, Inc., Rochester, NY). MS spectra
were obtained in an Agilent 5973 spectrometer (Agilent
Technologies, Inc., Santa Clara, CA). HPLC analyses were
performed in a Varian Pro Star instrument (Beckman
Instruments Inc., Irvine, CA) equipped with a Rheodyne
injection valve (20 mL) and a diode array detector (DAD)
set at 340 nm. Chromatograms were recorded and
processed using the Varian Star Chromatography
Workstation version 6.x (Beckman Instruments Inc.,
Irvine, CA). The water employed to prepare the mobile
phase was of ultrapure quality (Milliq). Methanol (J. T.
Baker) was of HPLC grade. Eupatorin and cirsimaritin
(Sigma, St. Louis, MO) were used as standards for HPLC
analysis. Silicagel (Merck, Darmstadt, Germany, 230–400
mesh) was used for column chromatographic separation
and Silicagel 60 F254 (Merck, Darmstadt, Germany) was
used for TLC analysis.
Plant material
The aerial parts of Stevia aristata D. Don ex Hook. &
Arn. (Asteraceae) (741) and Stevia entreriensis Hieron.
(Asteraceae) (762) were collected in the province of
Entre Rı́os, Argentina in November 2011 and March
2012, respectively. The aerial parts of Stevia satureiifolia
(Lam.) Sch. Bip. var. satureiifolia (Asteraceae) (744) and
Stevia multiaristata Spreng. (Asteraceae) (742) were
collected in the province of Buenos Aires, Argentina, in
February 2012.
The plant material was collected and identified by
one of the authors (Gustavo Giberti Ph.D.) and voucher
specimens were deposited at the Museo de
Farmacobotánica, Facultad de Farmacia y Bioquı́mica
(BAF), Universidad de Buenos Aires.
Parasites
Trypanosoma cruzi epimastigotes (RA strain) were
grown in a biphasic medium. Leishmania braziliensis
promastigotes (MHOM/BR/75/M2903) were grown in
liver infusion tryptose medium (LIT). Cultures were
routinely maintained by weekly passages at 28 C and
26 C, respectively.
Plant extracts
For the preparation of plant extracts for screening, 10 g
of the dried aerial parts of each Stevia species were
extracted by maceration (24 h) twice with 100 mL of
2 M. F. BEER ET AL.
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dichloromethane (DCM). The extracts were filtered and
taken to dryness. The extraction of S. satureiifolia var.
satureiifolia (aerial parts) for bioassay-guided fraction-
ation was performed using 500 g of plant material and
DCM (5 L) as described before above.
HPLC analysis of S. satureiifolia var. satureiifolia
dichloromethane extract (DCME)
A chromatografic profile of S. satureiifolia var. sature-
iifolia DCME was obtained using a Kinetex XB-C-18
100 Å (250 mm  46 mm  5 mm) column eluted with a
gradient of H2O:AcOH (98:2) (A) and MeOH:AcOH
(98:2) (B) from 50% B to 80% B in 40 min. The flow rate
employed was 1.2 mL/min. The DCME (5 mg) was
dissolved in MeOH:H2O (9:1) to a final concentration
of 5 mg/mL.
Fractionation and isolation of compounds from
S. satureiifolia var. satureiifolia extract
Stevia satureiifolia var. satureiifolia DCME (2.5 g) was
fractionated by column chromatography (CC) (400 mm
 30 mm) on Silicagel 60 (50 g) with a gradient of DCM
and ethyl acetate (EtOAc): DCM 100%, DCM:EtOAc 9:1,
3:1, 2:1, 1:1, 1:3, EtOAc 100%. Seven fractions (SS1–SS7)
of 100 mL each were collected and taken to dryness in a
rotatory evaporator. Each fraction was tested for
trypanocidal activity on T. cruzi epimastigotes. A
yellow precipitate (compound 3) (10 mg) was obtained
from fraction SS2 eluted with DCM: EtOAc 9:1. The TLC
analysis of fractions SS4 and SS5, eluted with
DCM:EtOAc 2:1 and 1:1, respectively, was performed
on Silicagel 60 F254, developed with hexane:EtOAc (1:9)
and Natural Products Reagent (Sigma, ST. Louis, MO) as
a revealing agent. Fraction SS5 (50 mg) was subjected to
CC (240 mm  20 mm) on Silicagel 60 (10 g) eluted with
a gradient of DCM and EtOAc: DCM 100%,
DCM:EtOAc 9:1, 7:3, 5:5, 3:7, 2:8, 1:9, EtOAc 100%, to
obtain eight subfractions (SS5A–SS5H). From subfractions
SS5B–SS5D eluted with DCM:EtOAc 9:1, 7:3, 5:5, 3:7, an
amorphous powder (6 mg) was obtained (compound 1).
This compound was filtered and washed three times with
hexane and EtOAc. The purity of compounds 1 and 3
was assessed by HPLC and the compounds were assayed
for trypanocidal and leishmanicidal activities.
Identification of compounds
The structure elucidation of compound 3 was performed
by UV spectroscopy with the addition of diagnostic
reagents (Mabry et al. 1970), by proton nuclear magnetic
resonance (1H NMR) and by electron impact-mass
spectrometry (EI-MS). Spectra were compared with
those found in the literature.
Identification of compound 1 was performed by
HPLC/DAD against a eupatorin standard. Each sample
was dissolved in MeOH:H2O (9:1). Three different
chromatographic systems were used: (1) a Phenomenex
column C-18 Luna (2) (250 mm 4.6 mm 5 mm)
eluted with a gradient of H2O:HCOOH (19:1) (A) and
MeOH (B) from 50% B to 100% B in 35 min. The flow
rate was set at 1 mL/min. (2) The same column as that
used in system 1 eluted with a gradient of H2O:AcOH
(98:2) (A) and MeOH:AcOH (98:2) (B) from 15% B to
100% B in 60 min. The flow rate was set at 1.2 mL/min.
(3) The system was the same as that used for HPLC
analysis of S. satureiifolia var. satureiifolia DCME.
Compound 2 was identified in the DCME by HPLC/
DAD against a cirsimaritin standard, using the same
three solvent systems as those used for compound 1.
Quantification of compounds 1–3 in S. sature-
iifolia var. satureiifolia DCME
The quantification of compounds 1–3 was performed by
HPLC/DAD using system 3. Eupatorin, cirsimaritin
(Sigma, St. Louis, MO) and the isolated compound 3
were used as a reference and 1 mg of each compound was
dissolved in 25 mL of a mixture MeOH:H2O (9:1). The
DCME (5 mg) was dissolved in the same solvent mixture
to a final concentration of 5 mg/mL.
Activity assay on T. cruzi and L. braziliensis
The growth inhibition of T. cruzi epimastigotes and L.
braziliensis promastigotes was evaluated by a [3H]-
thymidine uptake assay as previously described (Sülsen
et al. 2008). Parasites were adjusted to a cell density of
1.5 106/mL and cultured in the presence of Stevia spp.
extracts, S. satureiifolia var. satureiifolia fractions (100
and 10 mg/mL) and compounds 1 and 3 (100–0.1mg/mL)
for 72 h. Benznidazole (5–20mM; Elea) and
Amphotericin B (0.27–1.6mM; ICN) were used as
positive controls. Radioactivity was measured as counts
per minute (cpm). The percentage of inhibition was
calculated as 100  {[(cpm of treated parasites)/(cpm of
untreated parasites)]  100}.
The trypanocidal effect of compounds 1 and 3 was
also tested on bloodstream trypomastigotes as previously
described (Sülsen et al. 2008). Briefly, mouse blood
containing trypomastigotes was diluted in complete LIT
medium to adjust the parasite concentration to
1.5 106/mL. Parasites were seeded (150 mL/well) by
duplicate in a 96-well microplate, and 2 mL of each
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compound (0–100mg/mL, final concentration) were
added per well. Plates were incubated for 24 h at 4 C
and the remaining live parasites were counted in a
haemocytometer. Live trypomastigotes were calculated as
{[(live parasites in wells after compound treatment)/(live
parasites in untreated wells)] 100}.
To evaluate the effect of the compounds 1 and 3 on
intracellular forms of T. cruzi, 96-well plates were seeded
with the non-phagocytic Vero cells at 5  103 per well in
100 mL of culture medium and incubated for 2 h at 37 C
in a 5% CO2 atmosphere. Cells were washed and infected
with transfected bloodstream trypomastigotes expressing
b-galactosidase (Sülsen et al. 2013) at a parasite:cell ratio
of 10:1. After 24 h of co-culture, plates were washed twice
with PBS to remove extracellular parasites and each pure
compound was added at 1–100mg/mL per well in 150mL
of fresh complete RPMI medium without phenol red
(Gibco, Rockville, MD). Controls included infected non-
treated cells (100% infection control) and uninfected
cells (0% infection control). The assay was developed 5 d
later by the addition of chlorophenolred-b-D-galactopyr-
anoside (CPRG) (100 mM) and 1% Nonidet P40. Plates
were then incubated for 4–6 h at 37 C and the
absorbance was measured at 570 nm in a microplate
reader (Bio-Rad Laboratories, Hercules, CA). The per-
centage inhibition was calculated as 100–{[(absorbance
of treated infected cells)/(absorbance of untreated
infected cells) 100} and the IC50 value was estimated.
Cytotoxicity assay
Vero cells were employed to determine the viability by
the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium
bromide (MTT) method (Sülsen et al. 2011). Cells
(5 105) were settled at a final volume of 150mL in a
flat-bottom 96-well microplate and were cultured at
37 C in a 5% CO2 atmosphere in the absence or
presence of increasing concentrations of the pure
compounds 1 and 3 (12.5–500mg/mL). After 24 h,
MTT was added at a final concentration of 1.5 mg/mL.
Plates were incubated for 2 h at 37 C. The purple
formazan crystals were dissolved by adding 150 mL of
ethanol and the absorbance was read at 570 nm in a
microplate reader. Results were calculated as the ratio
between the optical density in the presence and absence
of the compound multiplied by 100.
Statistical analysis
Results are presented as mean ± SEM. The statistical
significance was determined by using one-way analysis of
variance (ANOVA) employing the GraphPad Prism 5.0
software (GraphPad Software Inc., San Diego, CA).
Comparisons were referred to the control group. p values
of50.05 were considered significant.
Results
Trypanocidal activity of plant extracts
All the tested dichloromethane extracts showed para-
siticidal activity on T. cruzi epimastigotes at concentra-
tions of 100 and 10mg/mL. Stevia aristata and S.
satureiifolia var. satureiifolia extracts induced growth
inhibition percentages of 87.3 ± 0.3% and 90.9 ± 1.2% at a
concentration of 10mg/mL (Figure 1).
HPLC analysis of S. satureiifolia var. satureiifolia
dichloromethane extract (DCME)
The DCME was analyzed by HPLC and three major
compounds were detected: compounds 1 (rt: 14.4 min),
2 (rt: 15.5 min) and 3 (rt. 18.1 min) in order of elution
(Figure 2). The UV spectra indicated that these com-
pounds had a flavonoid structure.
Bioassay-guided fractionation of S. satureiifolia
var. satureiifolia
The DCME was fractionated using column chromatog-
raphy. Seven fractions were obtained and assayed on T.
cruzi epimastigotes. All the fractions (SS1–SS7) exerted
significant trypanocidal activity with growth inhibition
Figure 1. Trypanocidal activity of organic extracts of Stevia
aristata, Stevia aristata, Stevia satureifolia var. satureifolia, Stevia
multiaristata against T. cruzi epimastigotes. Epimastigotes were
cultured for 72 h at 28 C in the presence of the extracts at
concentrations of 100 and 10 mg/mL. Values represent
mean ± SEM from three independent experiments carried out
in triplicate.
4 M. F. BEER ET AL.
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percentages that were higher than 90% at 100 mg/mL. At
a concentration of 10mg/mL, fractions SS1–SS5 were the
most active ones with inhibition percentages that were
higher than 80% (data not shown). Compound 3 was
obtained as a yellow precipitate from fraction SS2. The
purification of fraction SS5 by CC yielded an amorphous
powder (compound 1).
Identification and quantification of compounds
Compound 3 was identified as 5-hydroxy-6,7,3040-
tetramethoxyflavone (5-desmethylsinensetin). Amorphous
powder. UV lmax (MeOH) nm: 338, 275, 250, 240. EIMS
(70 eV), m/z (rel. int.): 358: [M]+ (100), 343 (54), 329
(19), 315 (12), 298 (3), 257 (1), 181 (8), 167 (2), 153 (16),
149 (3). 1H-NMR (600 MHz, CDCl3):  3.96 (3H, s), 
4.00 (3H, s),  4.01 (3H, s),  4.02 (3H, s),  6.58 (1H, s,
H-3),  6.63 (1H, s, H-8),  7.01 (1H, d, J¼ 8.6 Hz, H-50),
 7.37 (1H, d, J¼ 2.1 Hz, H-20),  7.56 (1H, dd, J¼ 2.0
and 8.5 Hz, H-60), 12,78 (1H, s). These data are in
accordance with those reported in the literature
(González et al. 1978, 1988).
Compound 1 was identified as 5,30-dihydroxy 6,7,40-
trimethoxyflavone (eupatorin) by HPLC employing a
commercial standard. Compound 2, which had been
detected in the DCME, was identified as cirsimaritin by
HPLC employing a commercial standard. The structures
of eupatorin, cirsimaritin and 5-desmethylsinensetin are
shown in Figure 2. The content of these flavonoids was
1.3, 1.9 and 1.5% in the DCME, and 0.047, 0.068 and
0.054%, respectively, calculated on dry plant material.
Antiprotozoal activity of compounds
The effect of eupatorin and 5-desmethylsinensetin on T.
cruzi epimastigotes is shown in Figure 3. IC50 values,
calculated for both flavonoids, were 0.2 and 0.4 mg/mL,
respectively. IC50 values for both compounds on T. cruzi
trypomastigotes were 75.1 mg/mL (5-desmethylsinense-
tin) and 61.8 mg/mL (eupatorin) (Figure 4). On one
hand, the flavone 5-desmethylsinensetin showed mod-
erate activity on amastigotes, with an IC50 value of
78.7 mg/mL. On the other hand, eupatorin was not active
against this parasite stage (Figure 5). The flavones,
5-desmethylsinensetin and eupatorin, showed activity
against L. braziliensis promastigotes (IC50 value¼37.0
and 55.1 mg/mL, respectively) (Figure 6). The reference
drug benznidazole showed IC50 values of 1.3, 9.5 and
0.98 mg/mL against epimastigotes, trypomastigotes and
amastigotes, respectively. Amphotericin B had an IC50
value of 0.12 mg/mL for L. braziliensis promastigotes.
Cytotoxicity
Eupatorin and 5-desmethylsinensetin showed no cyto-
toxicity on Vero cells up to a concentration of 500 mg/mL
(Table 1).
Discussion
In the search for new natural antiprotozoal compounds,
four native Stevia species were evaluated for their activity
on T. cruzi epimastigotes. All the tested dichloromethane
Figure 2. HPLC profile of the dichloromethane extract of Stevia satureifolia var. satureifolia.
PHARMACEUTICAL BIOLOGY 5
D
ow
nl
oa
de
d 
by
 [
U
ni
ve
rs
id
ad
 d
e 
B
ue
no
s 
A
ir
es
],
 [
V
ir
gi
ni
a 
M
ar
tin
o]
 a
t 0
8:
38
 1
8 
M
ar
ch
 2
01
6 
extracts showed parasiticidal activity. Stevia satureifolia
var. satureifolia dichloromethane extract was selected
for bioassay-guided fractionation in order to isolate its
bioactive compounds. Three 6-methoxy flavones, eupa-
torin, cirsimaritin and 5-desmethylsinensetin, were
identified in this extract, being cirsimaritin the major
compound, as determined by HPLC. Eupatorin and
cirsimaritin have been previously reported in S. sature-
iifolia (Sosa et al. 1984). However, this is the first report
on the presence of 5-desmethylsinensetin in this
plant species.
Eupatorin and 5-desmethylsinensetin were isolated
by bioassay-guided fractionation and tested for their
trypanocidal and leishmanicidal activities. Cirsimaritin
was not included in this study since it has been
previously reported to be active against T. cruzi and
Leishmania sp. with moderate cytotoxicity on Vero cells
(Tasdemir et al. 2006). Trypanosoma cruzi epimastigotes
and trypomastigotes proved to be susceptible to both
Figure 5. Trypanocidal activity of eupatorin and 5-desmethylsi-
nensetin on T. cruzi amastigotes. Vero cells infected with
transfected bloodstream trypomastigotes expressing -galacto-
sidase were incubated for 5 d in the presence of the compounds
(0–100mg/mL). The presence of amastigotes was developed
later by adding chlorophenolred--D-galactopyranoside in the
presence of Nonidet P40 and incubated for 4 h. The absorbance
was measured at 595 nm. Results are expressed as mean ± SEM.
Figure 3. Effect of eupatorin and 5-desmethylsinensetin on T.
cruzi epimastigotes. Parasites were cultured for 72 h at 28 C in
the presence of final compound concentrations ranging from 0.1
to 50 mg/mL. Results are expressed as mean ± SEM.
Figure 4. Trypanocidal activity of eupatorin and 5-desmethylsi-
nensetin on T. cruzi trypomastigotes. Parasites were seeded in a
96-well microplate over 24 h at 4 C in the presence of the
compounds (0–100mg/mL), and the remaining live parasites
were counted in a Neubauer chamber. Results are expressed as
mean ± SEM.
Figure 6. Leishmanicidal activity of eupatorin and 5-desmethyl-
sinensetin on L. braziliensis. Parasites were cultured for 72 h at
26 C in the presence of final compound concentrations ranging
from 0.1 to 100mg/mL. Results are expressed as mean ± SEM.
Table 1. Vero cells viability after treatment with eupatorin and
5-desmethylsinensetin.
Viability (media ± SEM)
Concentration (mg/mL) Eupatorin 5-Desmethylsinensetin
500 88.4 ± 1.3 90.7 ± 1.1
100 96.4 ± 3.2 97.7 ± 1.2
50 95.0 ± 4.5 92.3 ± 3.7
25 99.6 ± 0.8 96.4 ± 1.2
12.5 98.7 ± 5.9 98.5 ± 1.3
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eupatorin and 5-desmethylsinensetin. When these com-
pounds were assayed against the intracellular stage of the
parasites in mammalian cells, only 5-desmethylsinense-
tin was moderately active. This compound was also the
most active against L. braziliensis promastigotes.
Nevertheless, the isolated compounds were less active
than the reference drugs.
In order to determine the selectivity of the isolated
compounds, the cytotoxicity of eupatorin and 5-
desmethylsinensetin on Vero cells was evaluated.
Neither of the flavonoids showed cytotoxicity, indicating
that these compounds have the capacity to inhibit the
parasite growth without displaying a significant toxicity
on the host’s cell.
According to the literature, 6-methoxyflavones have
been reported as having antiprotozoal activity (Schmidt
et al. 2012). In this sense, we have previously found that
hispidulin and santin were active in vitro against T. cruzi
epimastigotes and trypomastigotes as well as on L.
mexicana promastigotes, with low cytotoxicity against
murine T cells (Sülsen et al. 2007). Our present findings
support the importance of these kinds of flavonoids as
trypanocidal and leishmanicidal leads.
Conclusion
The antiprotozoal activity of 5-desmethylsinensetin and
eupatorin, together with their low toxicity on Vero cells,
makes them attractive leads for the discovery of new
drugs against T. cruzi and Leishmania spp.
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Sülsen V, Cazorla S, Frank F, Redko FC, Anesini CA, Coussio
JD, Malchiodi EL, Martino VS, Muschietti LV. 2007.
Trypanocidal and leishmanicidal activities of flavonoids
from Argentine medicinal plants. Am J Trop Med Hyg.
77:654–659.
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